Choreo LLC Decreases Stake in Waters Corporation $WAT

Choreo LLC decreased its holdings in shares of Waters Corporation (NYSE:WAT) by 73.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 720 shares of the medical instruments supplier’s stock after selling 1,954 shares during the quarter. Choreo LLC’s holdings in Waters were worth $251,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of WAT. UMB Bank n.a. boosted its position in Waters by 2.8% during the second quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 29 shares during the last quarter. Integrated Wealth Concepts LLC lifted its stake in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares in the last quarter. Penserra Capital Management LLC boosted its holdings in shares of Waters by 13.1% during the 2nd quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock worth $114,000 after purchasing an additional 38 shares during the last quarter. Horizon Investments LLC grew its position in shares of Waters by 5.2% in the first quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier’s stock valued at $314,000 after purchasing an additional 42 shares in the last quarter. Finally, Parallel Advisors LLC grew its position in shares of Waters by 5.3% in the second quarter. Parallel Advisors LLC now owns 849 shares of the medical instruments supplier’s stock valued at $296,000 after purchasing an additional 43 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

Shares of Waters stock opened at $394.41 on Friday. The firm has a market cap of $23.48 billion, a PE ratio of 36.25, a price-to-earnings-growth ratio of 3.60 and a beta of 1.16. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. Waters Corporation has a 52 week low of $275.05 and a 52 week high of $423.56. The business’s fifty day simple moving average is $360.46 and its 200-day simple moving average is $332.34.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a net margin of 20.89% and a return on equity of 36.59%. The firm had revenue of $608.55 million for the quarter. Equities analysts forecast that Waters Corporation will post 12.86 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages recently commented on WAT. Redburn Partners set a $390.00 price objective on Waters in a research report on Wednesday, October 8th. Rothschild & Co Redburn started coverage on Waters in a report on Wednesday, October 8th. They set a “buy” rating and a $390.00 price target on the stock. Cowen reissued a “hold” rating on shares of Waters in a research report on Wednesday, November 5th. TD Cowen upped their price objective on shares of Waters from $345.00 to $390.00 and gave the company a “hold” rating in a report on Wednesday, November 5th. Finally, Morgan Stanley initiated coverage on shares of Waters in a research report on Monday. They set an “equal weight” rating and a $423.00 price objective for the company. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and ten have given a Hold rating to the stock. Based on data from MarketBeat, Waters currently has a consensus rating of “Moderate Buy” and an average price target of $384.33.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.